Overexpression of PLIN2 has been reported in various tumors, including Burkitt lymphoma [47], malignant melanoma [48], renal cell carcinoma [49], lung adenocarcinoma [50], and breast cancer [51]. This evidence concerns the gene PLIN2 and breast carcinoma.